Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
XERIS PHARMACEUTICALS INC (XERS)
|
|
| Operating Efficiency |
|
|
|
|
Annual |
|
| In millions, except per share items | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 |
| | Source | Source | Source | Source | Source |
| Turnover Ratios |
| Inventory turnover | 1.8 | 1.5 | | | |
| Asset turnover | 0.2 | 0.0 | 0.0 | | |
| |
| Returns on Capital |
| ROIC (excluding intangibles) | -105.7% | -189.6% | -178.2% | | |
| ROIC (including intangibles) | -87.8% | -194.6% | -89.3% | -13638.4% | |
| ROE | -247.8% | -850.8% | -78.7% | -66.5% | |
| ROA | -52.6% | -112.7% | -49.4% | -59.2% | |
| |
| Cash Conversion Cycle |
| Days sales outstanding | 124.5 | 1,052.8 | | 27,352.2 | |
| Days payables outstanding | 122.0 | 1,275.8 | -130.5 | 180,310.0 | |
| Days inventory outstanding | 326.8 | 495.5 | | | |
| Cash conversion cycle | 329.4 | 272.5 | | -152,957.8 | |
|